Please enable JavaScript to continue using this application.

Compare $DNTH vs $SRRK | Chartloom

Compare

$DNTH vs $SRRK

Dianthus Therapeutics Inc · Scholar Rock Holding Corp

DNTH

Dianthus Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Compare $DNTH vs $SRRK

Comparing Dianthus Therapeutics Inc and Scholar Rock Holding Corp

DNTHDianthus Therapeutics Inc

SRRKScholar Rock Holding Corp

DNTHDianthus Therapeutics Inc

Market cap

$4.50B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3,009.80x

Rev growth (TTM)

-60.8%

YTD performance

107.6%

52W performance

137.0%

FCF yield

-3.5%

SRRKScholar Rock Holding Corp

Market cap

$5.06B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

122.55x

Rev growth (TTM)

—

YTD performance

-1.4%

52W performance

9.0%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DNTH

SRRK

Detailed metrics comparison

DNTH

Dianthus Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Market Cap

DNTH$4.50B

SRRK$5.06B

Enterprise Value

DNTH$4.39B

SRRK$4.81B

Price

DNTH$82.37

SRRK$42.19

P/E Ratio

DNTHN/A

SRRKN/A

P/S Ratio

DNTH2,365.11x

SRRK120.52x

EV/Sales

DNTH2,307.05x

SRRK115.43x

EV/EBITDA

DNTH0.00x

SRRK0.00x

P/B Ratio

DNTH4.21x

SRRK22.46x

P/FCF Ratio

DNTHN/A

SRRKN/A

EV/FCF

DNTH-28.21x

SRRK-16.21x

PEG Ratio

DNTHN/A

SRRKN/A

Forward P/E (NTM)

DNTHN/A

SRRKN/A

Forward P/S (NTM)

DNTH3,009.80x

SRRK122.55x

Revenue (TTM)

DNTH$2M

SRRK$0

Revenue Growth (YoY)

DNTH-60.8%

SRRKN/A

Forward Rev Growth

DNTH-5.4%

SRRK2628.0%

Gross Margin (TTM)

DNTH0.0%

SRRK0.0%

Operating Margin (TTM)

DNTH0.0%

SRRK0.0%

EBITDA Margin (TTM)

DNTH-11434.9%

SRRK0.0%

Net Margin (TTM)

DNTH-10097.0%

SRRK0.0%

FCF Margin (TTM)

DNTH-8178.0%

SRRKN/A

Net Income (TTM)

DNTH$-192M

SRRK$-406M

FCF (TTM)

DNTH$-156M

SRRK$-297M

EPS (TTM)

DNTH-$3.43

SRRK-$3.11

ROE (TTM)

DNTH-2253.0%

SRRK-15912.0%

ROA (TTM)

DNTH-2155.0%

SRRK-8660.0%

ROIC (TTM)

DNTH-2253.0%

SRRK-10069.0%

Cash

DNTH$111M

SRRK$437M

Debt

DNTH$0

SRRK$196M

Net Cash/Debt

DNTH$111M

SRRK$241M

Current Ratio (TTM)

DNTH26.10x

SRRK7.02x

Quick Ratio (TTM)

DNTH25.80x

SRRK6.84x

Debt/Equity (TTM)

DNTH0.00x

SRRK0.77x

Debt/Assets (TTM)

DNTH0.0%

SRRK0.0%

Interest Coverage (TTM)

DNTHN/A

SRRKN/A

Net Debt/EBITDA (TTM)

DNTH0.00x

SRRK0.00x

Beta

DNTH1.99

SRRK0.76

52W Performance

DNTH137.0%

SRRK9.0%

YTD Performance

DNTH107.6%

SRRK-1.4%

% from 52W High

DNTH-30.1%

SRRK-31.7%

% from 52W Low

DNTH155.6%

SRRK55.9%

Asset Turnover (TTM)

DNTH0.00x

SRRK0.16x

FCF Yield (TTM)

DNTH-3.5%

SRRK-5.9%

Earnings Yield (TTM)

DNTH-4.3%

SRRK-8.0%

Dividend Yield (TTM)

DNTHN/A

SRRKN/A

Rule of 40

DNTH-8,238.8

SRRK0.0

EV/GP/RG

DNTHN/A

SRRKN/A

Ticker research

View DNTH research View SRRK research

Metric	DNTH Dianthus Therapeutics Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$4.50B	$5.06B
Enterprise Value	$4.39B	$4.81B
Price	$82.37	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	2,365.11x	120.52x
EV/Sales	2,307.05x	115.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.21x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-28.21x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3,009.80x	122.55x
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-60.8%	N/A
Forward Rev Growth	-5.4%	2628.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11434.9%	0.0%
Net Margin (TTM)	-10097.0%	0.0%
FCF Margin (TTM)	-8178.0%	N/A
Net Income (TTM)	$-192M	$-406M
FCF (TTM)	$-156M	$-297M
EPS (TTM)	-$3.43	-$3.11
ROE (TTM)	-2253.0%	-15912.0%
ROA (TTM)	-2155.0%	-8660.0%
ROIC (TTM)	-2253.0%	-10069.0%
Financial Health
Cash	$111M	$437M
Debt	$0	$196M
Net Cash/Debt	$111M	$241M
Current Ratio (TTM)	26.10x	7.02x
Quick Ratio (TTM)	25.80x	6.84x
Debt/Equity (TTM)	0.00x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.99	0.76
52W Performance	137.0%	9.0%
YTD Performance	107.6%	-1.4%
% from 52W High	-30.1%	-31.7%
% from 52W Low	155.6%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.16x
FCF Yield (TTM)	-3.5%	-5.9%
Earnings Yield (TTM)	-4.3%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,238.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DNTH research	View SRRK research

Valuation

P/S Ratio

SRRK

120.52x

DNTH

2,365.11x

EV/FCF

DNTH

-28.21x

SRRK

-16.21x

Growth & revenue

Revenue Growth TTM

DNTH

-60.8%

Forward Revenue Growth

SRRK

2628.0%

DNTH

-5.4%

Profitability & performance

Gross Margin

DNTH

0.0%

SRRK

0.0%

ROE

DNTH

-2253.0%

SRRK

-15912.0%

FCF Yield %

DNTH

-3.5%

SRRK

-5.9%

52-Week Performance

DNTH

137.0%

SRRK

9.0%

Detailed metrics comparison

DNTH

Dianthus Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Market Cap

DNTH$4.50B

SRRK$5.06B

Enterprise Value

DNTH$4.39B

SRRK$4.81B

Price

DNTH$82.37

SRRK$42.19

P/E Ratio

DNTHN/A

SRRKN/A

P/S Ratio

DNTH2,365.11x

SRRK120.52x

EV/Sales

DNTH2,307.05x

SRRK115.43x

EV/EBITDA

DNTH0.00x

SRRK0.00x

P/B Ratio

DNTH4.21x

SRRK22.46x

P/FCF Ratio

DNTHN/A

SRRKN/A

EV/FCF

DNTH-28.21x

SRRK-16.21x

PEG Ratio

DNTHN/A

SRRKN/A

Forward P/E (NTM)

DNTHN/A

SRRKN/A

Forward P/S (NTM)

DNTH3,009.80x

SRRK122.55x

Revenue (TTM)

DNTH$2M

SRRK$0

Revenue Growth (YoY)

DNTH-60.8%

SRRKN/A

Forward Rev Growth

DNTH-5.4%

SRRK2628.0%

Gross Margin (TTM)

DNTH0.0%

SRRK0.0%

Operating Margin (TTM)

DNTH0.0%

SRRK0.0%

EBITDA Margin (TTM)

DNTH-11434.9%

SRRK0.0%

Net Margin (TTM)

DNTH-10097.0%

SRRK0.0%

FCF Margin (TTM)

DNTH-8178.0%

SRRKN/A

Net Income (TTM)

DNTH$-192M

SRRK$-406M

FCF (TTM)

DNTH$-156M

SRRK$-297M

EPS (TTM)

DNTH-$3.43

SRRK-$3.11

ROE (TTM)

DNTH-2253.0%

SRRK-15912.0%

ROA (TTM)

DNTH-2155.0%

SRRK-8660.0%

ROIC (TTM)

DNTH-2253.0%

SRRK-10069.0%

Cash

DNTH$111M

SRRK$437M

Debt

DNTH$0

SRRK$196M

Net Cash/Debt

DNTH$111M

SRRK$241M

Current Ratio (TTM)

DNTH26.10x

SRRK7.02x

Quick Ratio (TTM)

DNTH25.80x

SRRK6.84x

Debt/Equity (TTM)

DNTH0.00x

SRRK0.77x

Debt/Assets (TTM)

DNTH0.0%

SRRK0.0%

Interest Coverage (TTM)

DNTHN/A

SRRKN/A

Net Debt/EBITDA (TTM)

DNTH0.00x

SRRK0.00x

Beta

DNTH1.99

SRRK0.76

52W Performance

DNTH137.0%

SRRK9.0%

YTD Performance

DNTH107.6%

SRRK-1.4%

% from 52W High

DNTH-30.1%

SRRK-31.7%

% from 52W Low

DNTH155.6%

SRRK55.9%

Asset Turnover (TTM)

DNTH0.00x

SRRK0.16x

FCF Yield (TTM)

DNTH-3.5%

SRRK-5.9%

Earnings Yield (TTM)

DNTH-4.3%

SRRK-8.0%

Dividend Yield (TTM)

DNTHN/A

SRRKN/A

Rule of 40

DNTH-8,238.8

SRRK0.0

EV/GP/RG

DNTHN/A

SRRKN/A

Ticker research

View DNTH research View SRRK research

Metric	DNTH Dianthus Therapeutics Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$4.50B	$5.06B
Enterprise Value	$4.39B	$4.81B
Price	$82.37	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	2,365.11x	120.52x
EV/Sales	2,307.05x	115.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.21x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-28.21x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3,009.80x	122.55x
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-60.8%	N/A
Forward Rev Growth	-5.4%	2628.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11434.9%	0.0%
Net Margin (TTM)	-10097.0%	0.0%
FCF Margin (TTM)	-8178.0%	N/A
Net Income (TTM)	$-192M	$-406M
FCF (TTM)	$-156M	$-297M
EPS (TTM)	-$3.43	-$3.11
ROE (TTM)	-2253.0%	-15912.0%
ROA (TTM)	-2155.0%	-8660.0%
ROIC (TTM)	-2253.0%	-10069.0%
Financial Health
Cash	$111M	$437M
Debt	$0	$196M
Net Cash/Debt	$111M	$241M
Current Ratio (TTM)	26.10x	7.02x
Quick Ratio (TTM)	25.80x	6.84x
Debt/Equity (TTM)	0.00x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.99	0.76
52W Performance	137.0%	9.0%
YTD Performance	107.6%	-1.4%
% from 52W High	-30.1%	-31.7%
% from 52W Low	155.6%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.16x
FCF Yield (TTM)	-3.5%	-5.9%
Earnings Yield (TTM)	-4.3%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,238.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DNTH research	View SRRK research